Third Eye has to be thrilled....
According to the May 1 2018 PR about advancing the closing documentation on the loan they were to receive 3,500,000 warrants priced at $1.30...at $4.00 those warrants are in the money to the tune of $2.70...that over $9.4 million right there, on top of the fees and interest payments. And if Apabetalone proves that it does everything this trial is hoping to prove it does...I would not be surprised if Resverlogix's MCap got up around $5 billion, which would be more than an 8 fold increase on the current MCap of around $600 million USD.
Looking forward to the trading tomorrow....g'night.
News 
Market Data 
Discover 
